Replies to post #279303 on Avid Bioservices Inc (CDMO)

[jakedogman1]

and pd1 only worked w/ 30% yet $40 bil market cap attributable to such losers...

the best hitters in baseball fail 70% of time yet get paid millions..

if they can demonstrate where bavi can be effective then value should follow..

also, b2gp1 is still a mystery...

[biopharm]

We shall see, muaybe PS targeting provides 109%+ better MOS and those Docetaxel arms will never likely never outperform again unless matched with PS Targeting